Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

China flag China · Delayed Price · Currency is CNY
14.65
+0.49 (3.46%)
Jan 23, 2026, 3:04 PM CST
55.36%
Market Cap2.58B
Revenue (ttm)244.84M
Net Income (ttm)-69.85M
Shares Out176.00M
EPS (ttm)-0.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,326,640
Average Volume1,421,810
Open13.42
Previous Close14.16
Day's Range13.42 - 14.82
52-Week Range5.77 - 17.49
Beta0.36
RSI61.15
Earnings DateApr 27, 2026

About SHE:002898

Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proto... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 514
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002898
Full Company Profile

Financial Performance

Financial Statements